evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
11867,GENE_SUMMARY,,VHL is a tumor suppressor involved in protein degradation. Germline mutations of VHL are associated with Von Hippel-Lindau syndrome and predispose to renal cell carcinoma.,,2017-04-28,,7428,VHL,von Hippel-Lindau tumor suppressor,False,ENST00000256474,NM_000551.3,HRCA1,pVHL,VHL1,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11868,GENE_BACKGROUND,,"The VHL gene encodes two VHL proteins (pVHL30 and pVHL19), which likely exhibit similar functions and act as tumor suppressors (PMID: 10102622, 9671762). The VHL protein forms a complex with transcription elongation factors C and B. This complex is critical for VHL protein function, as it stabilizes the protein and prevents proteasomal degradation. VHL mutations that disrupt this complex lead to an unstable VHL protein that is aberrantly degraded (PMID: 7660130, 7660122). Under normoxic conditions, VHL also plays a crucial role in the regulation of the hypoxia-inducible transcription factors (HIFs). HIF binding to the beta-domain of VHL leads to its ubiquitination and degradation (PMID: 10878807). HIFs are responsible for transcription of numerous genes in response to hypoxic conditions, including pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Loss of VHL leads to inappropriate activation of HIF downstream target genes, thus promoting tumorigenesis in normoxic conditions (PMID: 21386872). Functional inactivation of VHL has been reported through bi-allelic loss of the VHL gene in cases of 3p deletion (PMID: 2885753), heterozygous VHL mutations (PMID: 7915601, 21715564) or promoter methylation (PMID: 7937876). VHL loss can cause hereditary and sporadic forms of von Hippel-Lindau disease, which is associated with clear cell renal cell carcinoma, retinal hemangioblastomas, phaeochromocytomas and pancreatic neuroendocrine tumors (PMID: 18676741, 25533676).",,2017-04-28,,7428,VHL,von Hippel-Lindau tumor suppressor,False,ENST00000256474,NM_000551.3,HRCA1,pVHL,VHL1,True,7915601,Mutations of the VHL tumour suppressor gene in renal carcinoma.,Nature genetics,0001-05-01,7,True,85-90,Gnarra JR et al,,,0001-05-01,,7660130,Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.,"Science (New York, N.Y.)",0001-09-08,269,5229,1444-6,Kibel A et al,,,0001-09-08,,2885753,Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.,Nature,0001-06-25,327,6124,721-4,Zbar B et al,,,0001-06-25,,25533676,"VHL, the story of a tumour suppressor gene.",Nature reviews. Cancer,2018-01-01T20:15:00,15,True,55-64,Gossage L et al,doi: 10.1038/nrc3844,,0001-01-01,,7937876,Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.,Proceedings of the National Academy of Sciences of the United States of America,0001-10-11,91,21,9700-4,Herman JG et al,,,0001-10-11,,9671762,"A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.",Proceedings of the National Academy of Sciences of the United States of America,0001-07-21,95,15,8817-22,Schoenfeld A et al,,,0001-07-21,,7660122,Inhibition of transcription elongation by the VHL tumor suppressor protein.,"Science (New York, N.Y.)",0001-09-08,269,5229,1402-6,Duan DR et al,,,0001-09-08,,21386872,von Hippel-Lindau disease: a clinical and scientific review.,European journal of human genetics : EJHG,2018-06-01T20:11:00,19,6,617-23,Maher ER et al,doi: 10.1038/ejhg.2010.175,,0001-06-01,,18676741,Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-08-01T20:08:00,14,15,4726-34,Nickerson ML et al,doi: 10.1158/1078-0432.CCR-07-4921,,0001-08-01,,10102622,Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.,Oncogene,0001-02-25,18,8,1529-35,Blankenship C et al,,,0001-02-25,,21715564,VHL gene mutations and their effects on hypoxia inducible factor HIFÎ±: identification of potential driver and passenger mutations.,Cancer research,2018-08-15T20:11:00,71,16,5500-11,Rechsteiner MP et al,doi: 10.1158/0008-5472.CAN-11-0757,,0001-08-15,,10878807,Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.,Nature cell biology,2018-07-01T20:00:00,2,7,423-7,Ohh M et al,,,0001-07-01,
